Skip to content
Open·Ingested 90 days ago, not re-verified since

DoW Tuberous Sclerosis Complex, Clinical Translational Research Award

Defense Health Agency Contracting Activity - DHACA

Go to the official application

Free. Verify your email, then we send one reminder only.

Posted
May 5, 2026
Amount
$3,500,000
Closes
Aug 6, 2026 (in 2 days)

Get alerted when new grant funding like this opens.

Checking your account…

Free. Everyone sees new listings after 10 days. Unsubscribe anytime.

Classification and identifiers

Solicitation number
HT942526TSCRPCTRA
Assistance listing (CFDA)
12.420

Amount

$3,500,000

Who can apply

Open to all

About this opportunity

Summary: The fiscal year 2026 (FY26) Tuberous Sclerosis Complex Research Program (TSCRP) Clinical Translational Research Award (CTRA) supports studies that will move promising, well-founded preclinical and/or clinical research findings closer to clinical application, including diagnosis, prognosis or treatment of tuberous sclerosis complex (TSC). Distinctive Features: This funding mechanism allows for multiple Principal Investigators (PIs). Only the initiating PI will submit a pre-application, but all PIs will need to submit full applications. The partnering PI(s) application is an abbreviated package specific to their distinct portion of the research project. Be advised, all associated applications for a research project may be withdrawn if the initiating or partnering application is reje...

Refine this search